SCHEMBL21481671

SCHEMBL21481671

CC(C)Oc1nc(N)c2cnn(Cc3ccncc3)c2n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.50
CYP2D6 P10635 4/20 0.49
KDM4E B2RXH2 2/20 0.40
NR3C1 P04150 1/20 0.37
ABL1 P00519 1/20 0.36
BCR P11274 1/20 0.36
ADORA2A P29274 3/20 0.35
ADORA1 P30542 3/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPK1 P28482 2/20 0.35
HSD17B10 Q99714 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP17A1 P05093 1/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21481605 0.79 TLR7 (0.53) CYP3A4CYP2D6KDM4EADORA2AADORA1
SCHEMBL21481670 0.78 KDM4E (0.46) CYP3A4CYP2D6KDM4ENR3C1ABL1
SCHEMBL21462256 0.78 CYP3A4 (0.50) CYP3A4CYP2D6KDM4EABL1BCR
SCHEMBL21481609 0.76 CYP3A4 (0.64) CYP3A4CYP2D6TLR7
SCHEMBL21482074 0.76 CYP3A4 (0.64) CYP3A4CYP2D6TLR7
SCHEMBL21482073 0.76 CYP3A4 (0.64) CYP3A4CYP2D6TLR7
SCHEMBL21482029 0.75 CYP3A4 (0.70) CYP3A4CYP2D6CASP1TLR7
SCHEMBL21482036 0.73 CYP3A4 (0.71) CYP3A4CYP2D6TLR7
SCHEMBL21465871 0.73 CYP3A4 (0.71) CYP3A4CYP2D6TLR7
SCHEMBL21465870 0.73 CYP3A4 (0.71) CYP3A4CYP2D6TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019196918-A1 FIVE-MEMBERED HETEROCYCLO-PYRIMIDINE COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF 罗欣药业(上海)有限公司 2019-10-17 WO disclosed